Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.603ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.603ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.603EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.603EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.603ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.603ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.70EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.70ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.70ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.70EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.70EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.606EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.606EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.606ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.606ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.606EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.606EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.606ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.606ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GY.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GY.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GY.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GY.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JC.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JC.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JC.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JC.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JC.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.564EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.564EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.564ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used